Fig. 4.
Scatterplot of placebo-adjusted change from baseline in QTcI interval from 12-lead Holter versus observed plasma FTD concentration for all patients (cardiac safety population). FTD trifluridine, PBO placebo
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.